Marker Therapeutics Statistics
Total Valuation
MRKR has a market cap or net worth of $24.51 million. The enterprise value is $9.59 million.
| Market Cap | 24.51M |
| Enterprise Value | 9.59M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MRKR has 16.67 million shares outstanding. The number of shares has increased by 82.16% in one year.
| Current Share Class | 16.67M |
| Shares Outstanding | 16.67M |
| Shares Change (YoY) | +82.16% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 7.42% |
| Owned by Institutions (%) | 15.64% |
| Float | 13.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.91 |
| Forward PS | 7.79 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.79
| Current Ratio | 4.79 |
| Quick Ratio | 4.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -77.04% and return on invested capital (ROIC) is -53.05%.
| Return on Equity (ROE) | -77.04% |
| Return on Assets (ROA) | -43.59% |
| Return on Invested Capital (ROIC) | -53.05% |
| Return on Capital Employed (ROCE) | -87.02% |
| Weighted Average Cost of Capital (WACC) | 12.25% |
| Revenue Per Employee | $709,334 |
| Profits Per Employee | -$2.18M |
| Employee Count | 5 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -15,156 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.65% in the last 52 weeks. The beta is 1.45, so MRKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -2.65% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.36 |
| Relative Strength Index (RSI) | 57.13 |
| Average Volume (20 Days) | 56,556 |
Short Selling Information
The latest short interest is 217,647, so 1.31% of the outstanding shares have been sold short.
| Short Interest | 217,647 |
| Short Previous Month | 204,416 |
| Short % of Shares Out | 1.31% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, MRKR had revenue of $3.55 million and -$10.90 million in losses. Loss per share was -$0.63.
| Revenue | 3.55M |
| Gross Profit | -7.96M |
| Operating Income | -12.01M |
| Pretax Income | -10.91M |
| Net Income | -10.90M |
| EBITDA | n/a |
| EBIT | -12.01M |
| Loss Per Share | -$0.63 |
Balance Sheet
The company has $14.92 million in cash and n/a in debt, with a net cash position of $14.92 million or $0.89 per share.
| Cash & Cash Equivalents | 14.92M |
| Total Debt | n/a |
| Net Cash | 14.92M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 13.80M |
| Book Value Per Share | 0.83 |
| Working Capital | 13.80M |
Cash Flow
| Operating Cash Flow | -7.92M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -7.92M |
| FCF Per Share | -$0.47 |
Margins
| Gross Margin | -224.43% |
| Operating Margin | -338.49% |
| Pretax Margin | -307.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MRKR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -82.16% |
| Shareholder Yield | -82.16% |
| Earnings Yield | -44.46% |
| FCF Yield | -32.31% |
Analyst Forecast
The average price target for MRKR is $7.87, which is 435.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.87 |
| Price Target Difference | 435.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 187.04% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MRKR has an Altman Z-Score of -35.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.26 |
| Piotroski F-Score | 1 |